
Meta-Analysis Boosts Soy for Hot Flash Relief
Compared to placebo, soy isoflavone consumption was linked to significant reduction in hot flash frequency (20.6%) and severity (26.2%).
Soy isoflavone’s reputation for menopause relief is often debated, but a new meta-analysis of human trials suggests the ingredient can provide significant
Researchers from Japan and the United States looked at 17 trials measuring changes in hot flash frequency and/or severity when women consumed soy isoflavone dietary supplements. Compared to placebo, soy isoflavone consumption was linked to significant reduction in hot flash frequency (20.6%) and severity (26.2%). When the dietary supplement provided more than 18.8 mg of the soy isoflavone genistein, hot flash reduction was three times as effective as results with low-genistein consumption.
Long-term trials showed greater potential of hot flash relief than short-term trials.
Participants in the trials consumed a median amount of 54 mg of soy isoflavone daily. Soy isoflavone supplier Archer Daniels Midland Company (Decatur, IL) says the meta-analysis is the largest and most comprehensive conducted to date.





